← Back to All Filings

ISRG Director Sells $435k in Stock via 10b5-1 Plan

Low SignificanceNovember 13, 2025 at 2:02:35 PM EST

INTUITIVE SURGICAL INC

$ISRG4CIK: 0001035267

Subscribe to track ISRG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ISRG Director Sells $435k in Stock via 10b5-1 Plan

Company: INTUITIVE SURGICAL INC (ISRG) Form: 4 | Filed: 2025-11-13 Significance: Low

Insider: BARRATT CRAIG H Title: null | Relationship: Director

Transaction: • Type: Sell (following option exercise) • Shares: 750 • Price: $580.00 • Value: $435,000 • Owned After: 27,198

Key Insight: This was a pre-scheduled sale under a 10b5-1 plan, where the insider exercised options and immediately sold the acquired shares. The transaction value is negligible relative to ISRG's $204B market cap.

Market Context: Such pre-planned sales are common for executive compensation and are generally considered to have low informational value for the market.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: INTUITIVE SURGICAL INC (ISRG)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director conducted a routine, pre-planned cashless exercise of stock options and sold the resulting shares, a common practice for compensation.
  • Market Impact: The transaction is immaterial relative to the company's market capitalization and is unlikely to influence the stock price.

Company Information

FieldValue
CompanyINTUITIVE SURGICAL INC
Ticker SymbolISRG
CIK0001035267
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

Insider Information

FieldValue
NameBARRATT CRAIG H
CIK0001277620
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-12
Transaction CodeS (Sale) / M (Option Exercise)
Security TypeCommon Stock
Shares Involved750
Price Per Share$580.00
Total Value$435,000
Shares Owned After27,198
Ownership TypeDirect sale, remaining shares held Indirectly by Trust

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$435,000
% of Market Cap0.00021%
Shares Transacted750
% of Shares Outstanding0.00021%
Post-Transaction Ownership27,198 shares (0.0076% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company with a market capitalization of $204.26 billion, a transaction valued at $435,000 is financially insignificant.
  • Ownership Concentration: The insider's post-transaction ownership of 27,198 shares represents a very small fraction of the total shares outstanding, indicating low ownership concentration.
  • Transaction Significance: The sale represents a negligible percentage of both the market cap and shares outstanding, confirming its low materiality. The sale of 750 shares is a small portion of the insider's total holdings.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, which divorces the sale from any potential non-public information the insider might possess. The size of the transaction is de minimis for a company of ISRG's scale.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction size is too small to have a noticeable effect on trading volume.
  • Sentiment Indicator: Neutral. This is a routine, pre-planned disposition of shares acquired through an option exercise and does not signal a change in the insider's outlook on the company.

Additional Context

Transaction Notes

  • Special Circumstances: The filing explicitly states the transaction was made under a Rule 10b5-1 trading plan. This was a cashless exercise where the insider exercised options to acquire 750 shares at $71.3233 and simultaneously sold them at $580.00.
Topics:#ISRG#IntuitiveSurgical#InsiderTrading#SECFiling#Form4#InsiderSell#StockMarket#Investing#10b51

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.